← Eichor
Study identifier: NCT06776601 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Digital Therapy in Self-management of COPD Patients

Condition: Chronic Obstructive Pulmonary Disease  ·  Sponsor: China-Japan Friendship Hospital

PhaseNA
Planned participants600
Who can joinAll sexes, 40 Years to no upper limit
Healthy volunteersNo

About this study

This project adopts a whole-process digital therapy intervention package composed of an inhalation technique assessment device, an electronic inhalant medication monitoring device and digital software to guide patients use the inhaler correctly personalizedly, record and manage the behavior data of chronic obstructive pulmonary disease (COPD) patients during the use of inhalant medication, and provide personalized reminders and feedback to patients according to the data. The purpose is to analyze whether this digital intervention scheme can reduce the number of acute exacerbations of COPD, improve the management effect of COPD, and reduce the burden of disease by improving the medication compliance of COPD patients.

This description comes directly from the study's public registry record.

Talk to the study team

Hanna Wu, MD  ·  86+15827502015  ·  wuhanna0506@163.com

Hongtao Niu, PhD  ·  86+15810610306  ·  oxhongtao@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

China Japan Friendship HospitalBeijing, Beijing Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06776601